Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Aug 11, 2025

Accession no.
0001628280-25-039411
Filed
Aug 11, 2025
Trade date
Jul 1-31, 2025
Filing delay
41 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 22 non-derivative transactions and 0 derivative transactions. Open-market purchases total $577.9. It was filed 41 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2025Common StockPPurchaseAcquired+8$3.56+$28.4832,661Direct
Jul 2, 2025Common StockPPurchaseAcquired+8$3.52+$28.1632,669Direct
Jul 3, 2025Common StockPPurchaseAcquired+8$3.53+$28.2432,677Direct
Jul 7, 2025Common StockPPurchaseAcquired+8$3.23+$25.8432,685Direct
Jul 8, 2025Common StockPPurchaseAcquired+8$3.06+$24.4832,693Direct
Jul 9, 2025Common StockPPurchaseAcquired+8$3.05+$24.432,701Direct
Jul 10, 2025Common StockPPurchaseAcquired+8$3.20+$25.632,709Direct
Jul 11, 2025Common StockPPurchaseAcquired+8$3.21+$25.6832,717Direct
Jul 14, 2025Common StockPPurchaseAcquired+8$3.46+$27.6832,725Direct
Jul 15, 2025Common StockPPurchaseAcquired+8$3.45+$27.632,733Direct
Jul 16, 2025Common StockPPurchaseAcquired+8$3.79+$30.3232,741Direct
Jul 17, 2025Common StockPPurchaseAcquired+8$3.82+$30.5632,749Direct
Jul 18, 2025Common StockPPurchaseAcquired+8$3.59+$28.7232,757Direct
Jul 21, 2025Common StockPPurchaseAcquired+8$3.45+$27.632,765Direct
Jul 22, 2025Common StockPPurchaseAcquired+8$3.47+$27.7632,773Direct
Jul 23, 2025Common StockPPurchaseAcquired+8$3.54+$28.3232,781Direct
Jul 24, 2025Common StockPPurchaseAcquired+8$3.55+$28.432,789Direct
Jul 25, 2025Common StockPPurchaseAcquired+8$3.37+$26.9632,797Direct
Jul 28, 2025Common StockPPurchaseAcquired+6$3.47+$20.8232,803Direct
Jul 29, 2025Common StockPPurchaseAcquired+6$3.33+$19.9832,809Direct
Jul 30, 2025Common StockPPurchaseAcquired+6$3.55+$21.332,815Direct
Jul 31, 2025Common StockPPurchaseAcquired+6$3.50+$2132,821Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)